Pierre Laurent‐Puig
1,292 works · 70,343 citations · h-index 109
Top works
- Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
- KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer
- Mapping of a susceptibility locus for Crohn's disease on chromosome 16
- The consensus molecular subtypes of colorectal cancer
- KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
- Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
- Alleles of the APC gene: An attenuated form of familial polyposis
- Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
- Large-scale genotyping identifies 41 new loci associated with breast cancer risk
- Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC
- Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
- Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis
- Bi-allelic inactivation of TCF1 in hepatic adenomas
- Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients
- Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer
- Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability